Chronic kidney disease is among others characterized by a disturbed FGF23-associated mineral metabolism and studies support the concept that concomitant hyperphosphatemia may promote FGF23’s cardiac toxicity. The gene discussed is FGF23; the disease is hyperphosphatemia.